GlassScriptPhysician profile
Stephen Richard Weatherholtz
NPI 1578307468
$778.97
in general payments reported to CMS, 2019-2025
10 companies · $612 in 2025
The $612 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $167 · 2025: $612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $778.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $142.80 | 2025 | |
| Solventum Corporation | $130.16 | 2025 | V.A.C. Veraflo, V.A.C. Dermatac, Prevena |
| Kerecis Limited | $124.00 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Paragon 28, INC. | $109.54 | 2024-2025 | Portfolio, Precision Mis Bunion, Phantom Fibula Nail |
| Treace Medical Concepts, INC. | $83.84 | 2025 | |
| Linvatec Corporation | $54.28 | 2025 | Biobrace 23mm |
| Medline Industries LP | $53.27 | 2025 | |
| Biopro, INC. | $51.85 | 2025 | Hemi Toe |
| Surgenex LLC | $15.72 | 2025 | Renograft, Surmatrix, Ardeograft |
| Stryker Corporation | $13.51 | 2024 | Stryker |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephen Weatherholtz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.